BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36077344)

  • 1.
    Schweitzer T; Genth H; Pich A
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077344
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemorrhagic toxin and lethal toxin from Clostridium sordellii strain vpi9048: molecular characterization and comparative analysis of substrate specificity of the large clostridial glucosylating toxins.
    Genth H; Pauillac S; Schelle I; Bouvet P; Bouchier C; Varela-Chavez C; Just I; Popoff MR
    Cell Microbiol; 2014 Nov; 16(11):1706-21. PubMed ID: 24905543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques.
    Zeiser J; Gerhard R; Just I; Pich A
    J Proteome Res; 2013 Apr; 12(4):1604-18. PubMed ID: 23387933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human α-Defensin-6 Neutralizes
    Barthold L; Heber S; Schmidt CQ; Gradl M; Weidinger G; Barth H; Fischer S
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins.
    Chen S; Sun C; Wang H; Wang J
    Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the glucosyltransferase domain of TcdA in complex with RhoA provides insights into substrate recognition.
    Chen B; Liu Z; Perry K; Jin R
    Sci Rep; 2022 May; 12(1):9028. PubMed ID: 35637242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EhRho1, a RhoA-like GTPase of Entamoeba histolytica, is modified by clostridial glucosylating cytotoxins.
    Majumder S; Schmidt G; Lohia A; Aktories K
    Appl Environ Microbiol; 2006 Dec; 72(12):7842-8. PubMed ID: 17056697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile toxins A and B directly stimulate human mast cells.
    Meyer GK; Neetz A; Brandes G; Tsikas D; Butterfield JH; Just I; Gerhard R
    Infect Immun; 2007 Aug; 75(8):3868-76. PubMed ID: 17517880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells.
    Gerhard R; Nottrott S; Schoentaube J; Tatge H; Olling A; Just I
    J Med Microbiol; 2008 Jun; 57(Pt 6):765-770. PubMed ID: 18480335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in Mono-O-Glucosylation of Ras Subtype GTPases Between Toxin A and Toxin B From
    Genth H; Junemann J; Lämmerhirt CM; Lücke AC; Schelle I; Just I; Gerhard R; Pich A
    Front Microbiol; 2018; 9():3078. PubMed ID: 30622517
    [No Abstract]   [Full Text] [Related]  

  • 11. Time-resolved cellular effects induced by TcdA from Clostridium difficile.
    Jochim N; Gerhard R; Just I; Pich A
    Rapid Commun Mass Spectrom; 2014 May; 28(10):1089-100. PubMed ID: 24711272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of small GTPase glucosylation by clostridial glucosylating toxins using multiplexed MRM analysis.
    Junemann J; Lämmerhirt CM; Polten F; Just I; Gerhard R; Genth H; Pich A
    Proteomics; 2017 May; 17(9):. PubMed ID: 28252257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human peptide α-defensin-1 interferes with Clostridioides difficile toxins TcdA, TcdB, and CDT.
    Fischer S; Ückert AK; Landenberger M; Papatheodorou P; Hoffmann-Richter C; Mittler AK; Ziener U; Hägele M; Schwan C; Müller M; Kleger A; Benz R; Popoff MR; Aktories K; Barth H
    FASEB J; 2020 May; 34(5):6244-6261. PubMed ID: 32190927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of the host SLC11A1 gene by Clostridium difficile toxin B facilitates glucosylation of Rho GTPases and enhances toxin lethality.
    Feng Y; Cohen SN
    Infect Immun; 2013 Aug; 81(8):2724-32. PubMed ID: 23690404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in F-actin depolymerization induced by toxin B from the Clostridium difficile strain VPI 10463 and toxin B from the variant Clostridium difficile serotype F strain 1470.
    May M; Wang T; Müller M; Genth H
    Toxins (Basel); 2013 Jan; 5(1):106-19. PubMed ID: 23344455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TcdB of
    Stieglitz F; Gerhard R; Hönig R; Giehl K; Pich A
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Clostridium difficile TcdA and TcdB toxins with transition state analogues.
    Paparella AS; Aboulache BL; Harijan RK; Potts KS; Tyler PC; Schramm VL
    Nat Commun; 2021 Nov; 12(1):6285. PubMed ID: 34725358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins.
    Schirmer J; Aktories K
    Biochim Biophys Acta; 2004 Jul; 1673(1-2):66-74. PubMed ID: 15238250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a structural understanding of Clostridium difficile toxins A and B.
    Pruitt RN; Lacy DB
    Front Cell Infect Microbiol; 2012; 2():28. PubMed ID: 22919620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Density Lipoprotein Receptor-Related Protein-1 (LRP1) Is Involved in the Uptake of
    Schöttelndreier D; Langejürgen A; Lindner R; Genth H
    Front Cell Infect Microbiol; 2020; 10():565465. PubMed ID: 33194803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.